Surgical Science Sweden AB (publ) (STO:SUS)
Sweden
· Delayed Price · Currency is SEK 32.74
-0.18 (-0.55%)
Apr 29, 2026, 3:14 PM CET
STO:SUS Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 | Upgrade
|
| Cash & Short-Term Investments | 616.43 | 968.16 | 634.37 | 433.73 | 316.68 | Upgrade
|
| Cash Growth | -36.33% | 52.62% | 46.26% | 36.96% | 263.34% | Upgrade
|
| Accounts Receivable | 136.98 | 136.7 | 110.6 | 176.31 | 110.65 | Upgrade
|
| Other Receivables | 205.57 | 121.44 | 81.11 | 67.81 | 69.14 | Upgrade
|
| Receivables | 342.54 | 258.14 | 191.71 | 244.13 | 179.79 | Upgrade
|
| Inventory | 205.97 | 179.58 | 154.45 | 134.88 | 113.11 | Upgrade
|
| Prepaid Expenses | 19.74 | 20.13 | 10.67 | 13.63 | 7.33 | Upgrade
|
| Other Current Assets | - | 0 | - | - | - | Upgrade
|
| Total Current Assets | 1,185 | 1,426 | 991.19 | 826.37 | 616.91 | Upgrade
|
| Property, Plant & Equipment | 106.35 | 101.53 | 76.62 | 51.36 | 38.39 | Upgrade
|
| Goodwill | 3,077 | 3,616 | 3,329 | 3,444 | 3,019 | Upgrade
|
| Other Intangible Assets | 300.9 | 311.91 | 286.57 | 301.02 | 274.03 | Upgrade
|
| Long-Term Deferred Tax Assets | 13.58 | 16.33 | 14.84 | 22.16 | 24.6 | Upgrade
|
| Other Long-Term Assets | 8.62 | 8.05 | 4.77 | 4.37 | 4.97 | Upgrade
|
| Total Assets | 4,691 | 5,480 | 4,703 | 4,650 | 3,978 | Upgrade
|
| Accounts Payable | 36.25 | 58.45 | 41.29 | 65.69 | 34.37 | Upgrade
|
| Accrued Expenses | 86.31 | 58.12 | 47.34 | 44.27 | 104.18 | Upgrade
|
| Current Income Taxes Payable | 49.66 | 51.44 | 31.03 | 13.9 | 5.49 | Upgrade
|
| Current Unearned Revenue | 66.67 | 66.83 | 72.89 | 70.65 | 16.95 | Upgrade
|
| Other Current Liabilities | 53.87 | 277.89 | 42.39 | 111.4 | 71.39 | Upgrade
|
| Total Current Liabilities | 292.76 | 512.72 | 234.94 | 305.91 | 232.38 | Upgrade
|
| Long-Term Leases | 56.4 | 56.94 | 40.02 | 14.68 | 12.07 | Upgrade
|
| Long-Term Unearned Revenue | 15.27 | 19.47 | 20.29 | 27.62 | 20.49 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 33.45 | 43.55 | 45 | 51.51 | 48.51 | Upgrade
|
| Other Long-Term Liabilities | 20.44 | 18.36 | 17.21 | 13.4 | 79.61 | Upgrade
|
| Total Liabilities | 418.31 | 651.03 | 357.46 | 413.11 | 393.06 | Upgrade
|
| Common Stock | 2.55 | 2.55 | 2.55 | 2.54 | 2.54 | Upgrade
|
| Additional Paid-In Capital | 3,398 | 3,398 | 3,398 | 3,379 | 3,379 | Upgrade
|
| Retained Earnings | 706.23 | 639.41 | 507.76 | 273.79 | 85.82 | Upgrade
|
| Comprehensive Income & Other | 166.16 | 788.56 | 436.78 | 581.14 | 117.73 | Upgrade
|
| Shareholders' Equity | 4,273 | 4,829 | 4,345 | 4,236 | 3,585 | Upgrade
|
| Total Liabilities & Equity | 4,691 | 5,480 | 4,703 | 4,650 | 3,978 | Upgrade
|
| Total Debt | 56.4 | 56.94 | 40.02 | 14.68 | 12.07 | Upgrade
|
| Net Cash (Debt) | 560.03 | 911.22 | 594.34 | 419.05 | 304.61 | Upgrade
|
| Net Cash Growth | -38.54% | 53.31% | 41.83% | 37.57% | 259.05% | Upgrade
|
| Net Cash Per Share | 10.98 | 17.86 | 11.67 | 8.23 | 7.14 | Upgrade
|
| Filing Date Shares Outstanding | 51.03 | 51.03 | 51.03 | 50.8 | 50.8 | Upgrade
|
| Total Common Shares Outstanding | 51.03 | 51.03 | 51.03 | 50.8 | 50.8 | Upgrade
|
| Working Capital | 891.92 | 913.29 | 756.26 | 520.46 | 384.53 | Upgrade
|
| Book Value Per Share | 83.74 | 94.63 | 85.16 | 83.39 | 70.57 | Upgrade
|
| Tangible Book Value | 894.92 | 900.89 | 729.96 | 491.14 | 291.81 | Upgrade
|
| Tangible Book Value Per Share | 17.54 | 17.66 | 14.31 | 9.67 | 5.74 | Upgrade
|
| Machinery | 276.64 | 186.66 | 132.67 | 91.23 | 58.54 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.